PeterLabs Holdings Bhd (0171) - Total Liabilities
Based on the latest financial reports, PeterLabs Holdings Bhd (0171) has total liabilities worth RM21.70 Million MYR (≈ $5.45 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore PeterLabs Holdings Bhd net asset momentum to track the company's year-over-year net asset growth rate.
PeterLabs Holdings Bhd - Total Liabilities Trend (2015–2024)
This chart illustrates how PeterLabs Holdings Bhd's total liabilities have evolved over time, based on quarterly financial data. See 0171 free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.
PeterLabs Holdings Bhd Competitors by Total Liabilities
The table below lists competitors of PeterLabs Holdings Bhd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Zelan Bhd
KLSE:2283
|
Malaysia | RM524.27 Million |
|
Orion Digital Corp.
NASDAQ:ORIO
|
USA | $100.11 Million |
|
Narmada Agrobase Limited
NSE:NARMADA
|
India | Rs128.11 Million |
|
Bharat Road Network Limited
NSE:BRNL
|
India | Rs10.45 Billion |
|
Digicontent Limited
NSE:DGCONTENT
|
India | Rs2.16 Billion |
|
Gold Pacific Co. Ltd
KQ:038530
|
Korea | ₩8.14 Billion |
|
Puma Exploration Inc
V:PUMA
|
Canada | CA$1.38 Million |
|
Manganese X Energy Corp
V:MN
|
Canada | CA$59.62K |
Liability Composition Analysis (2015–2024)
This chart breaks down PeterLabs Holdings Bhd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see PeterLabs Holdings Bhd (0171) total market value.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.93 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.28 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.22 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how PeterLabs Holdings Bhd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for PeterLabs Holdings Bhd (2015–2024)
The table below shows the annual total liabilities of PeterLabs Holdings Bhd from 2015 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | RM34.09 Million ≈ $8.56 Million |
-8.23% |
| 2023-12-31 | RM37.15 Million ≈ $9.33 Million |
+16.63% |
| 2022-12-31 | RM31.85 Million ≈ $8.00 Million |
-18.63% |
| 2021-12-31 | RM39.15 Million ≈ $9.83 Million |
+159.78% |
| 2020-12-31 | RM15.07 Million ≈ $3.78 Million |
-25.62% |
| 2019-12-31 | RM20.26 Million ≈ $5.09 Million |
-17.46% |
| 2018-12-31 | RM24.55 Million ≈ $6.16 Million |
+5.89% |
| 2017-12-31 | RM23.18 Million ≈ $5.82 Million |
+3.87% |
| 2016-12-31 | RM22.32 Million ≈ $5.60 Million |
+93.89% |
| 2015-12-31 | RM11.51 Million ≈ $2.89 Million |
-- |
About PeterLabs Holdings Bhd
PeterLabs Holdings Berhad, an investment holding company, engages in manufacturing, distribution, trading, and export of animal health and nutrition products in Malaysia and internationally. The company operates through three segments: Manufacturing, Trading, and Others. It offers biosecurity products and disinfectants, compound feed supplements, feed additives, nutritional premixes, pharmaceutic… Read more